Who Really Drives Innovation

Why It Matters

The findings highlight why sustained public R&D spending is critical for long‑term economic growth and inform policymakers about the trade‑offs of budget reductions. They also offer a roadmap for other regions, like Europe, to recalibrate their innovation financing.

Key Takeaways

• Government‑funded patents represent 2% of filings but yield 20% productivity boost
• NIH and NSF drive the majority of high‑impact public research outcomes
• Public R&D crowds in private investment, delivering over double private R&D returns
• Cuts to federal science funding risk slowing long‑term US productivity growth
• Europe’s heavy procurement spending limits its ability to capture full innovation cycle

Pulse Analysis

The public origins of American innovation trace back to Vannevar Bush’s 1945 report, *Science: The Endless Frontier*, which laid out a three‑pillar model: federal funding to steer research, university labs to pursue basic science, and private firms to commercialize discoveries. This blueprint has guided decades of policy, from the Manhattan Project to the internet, creating a pipeline where government‑sponsored breakthroughs—often high‑risk and long‑term—are later transformed into market‑ready products. By institutionalizing basic research, the U.S. has cultivated a talent pool and knowledge base that private capital can efficiently leverage.

The CEPR paper leverages granular patent data that distinguishes government‑interest patents from fully private ones. Its core finding—that a modest 2% share of government‑funded patents drives 20% of productivity gains—reveals the disproportionate spillovers of publicly financed science. Agencies like the NIH and NSF dominate these high‑impact patents, especially in health and education research, which tend to generate broader economic externalities than defense‑focused projects. Moreover, the study quantifies a crowd‑in effect: each dollar of public R&D attracts more than a dollar of private investment, amplifying the overall return on government spending. While AI today is largely privately funded, the authors caution that without public direction, innovation may skew toward short‑term profit rather than societal benefit.

Policy implications are stark. Recent federal science budget cuts threaten to diminish the pipeline of foundational research, potentially curbing future productivity growth and ceding technological leadership to rivals like China. For Europe, the analysis suggests shifting resources from procurement‑heavy spending toward public R&D could unlock latent talent and improve the scaling of startups. As the U.S. debates its research agenda, the evidence underscores that sustained, well‑targeted public investment remains a cornerstone of long‑run economic dynamism.